PT - JOURNAL ARTICLE AU - Nuraini, N. AU - Khairudin, K. AU - Hadisoemarto, P. AU - Susanto, H. AU - Hasan, A. AU - Sumarti, N. TI - Mathematical Models for Assessing Vaccination Scenarios in Several Provinces in Indonesia AID - 10.1101/2020.12.21.20248241 DP - 2020 Jan 01 TA - medRxiv PG - 2020.12.21.20248241 4099 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248241.short 4100 - http://medrxiv.org/content/early/2020/12/22/2020.12.21.20248241.full AB - To mitigate more casualties from the COVID-19 outbreak, this study assessed optimal vaccination scenarios, considering some existing healthcare conditions and some assumptions, by developing SIQRD (Susceptible-Infected-Quarantine-Recovery-Death) models for Jakarta, West Java, and Banten, in Indonesia. The models included an age-structured dynamic transmission model that naturally could give different treatments among age groups of population. The simulation results show that the timing and period’s length of the vaccination should be well planned and prioritizing particular age groups will give significant impact on the total number of casualties.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData are provided in an online respiratory. https://github.com/agusisma/covidvaccine